chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Redness/Swelling and hot at injectionsite; Redness/Swelling and hot at injectionsite; Hot at injection site; This is a spontaneous report from a contactable consumer. A 77-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 12Apr2021 at 10:00 (at the age of 76-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 76-years-old), as a single dose for COVID-19 immunisation. On 15Apr2021, the patient experienced redness/swelling and hot at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events redness/swelling and hot at injection site were resolving at the time of reporting.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: At 12am on 15Apr my ears just started ringing. They have been consistently ringing since then; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 11Apr2021 at 16:15 (at the age of 32-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included iron (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and alive women's multivitamins; all for unspecified indication from unknown date and unknown if ongoing. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 00:00, the patient's ears just started ringing. They had been consistently ringing since then. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ears just started ringing was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Pain on the arm; High fever 39 C; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took ciproflaxacin and experienced drug allergy and  received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced pain on the arm, high fever 39 degree centigrade and tiredness. Therapeutic measures were taken as a result of the events which included treatment with paracetamol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain on the arm, high fever 39 C and tiredness were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Diffuse urticaria on abdomen, upper legs and axilla; This is a spontaneous report from a contactable physician. A 36-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11Apr2021 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, COVID-19 and history of urticaria but no clear causes were identified. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN), vitamin D (MANUFACTURER UNKNOWN) and amlodipine (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. On an unknown date in Apr2021, the patient experienced diffuse urticaria on abdomen, upper legs and axilla. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with prednisone. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diffuse urticaria on abdomen, upper legs and axilla were recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Headache, Limb mass, Nausea, Neuralgia
Clinical narrative: Pain in both armpits; Nausea; Headache; Swollen painful lump in arm; Tingling for 24 hours in right arm; Nerve pain for 24 hours in right arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 14:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included migraines, fibromyalgia, anxiety and depression. The patient had known allergies to penicillin, sulfa drugs, mango and pears. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and duloxetine hydrochloride (CYMBALTA); both for unspecified indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Apr2021 at 00:00, the patient experienced nausea, headache within a few hours of vaccination, swollen painful lump in arm and tingling nerve pain for 24 hours in right arm. On 15Apr2021 after 2 days of vaccination, the patient experienced pain in both armpits which continued for at least 48 hours (at the time of reporting). The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, headache, swollen painful lump in arm, pain in both armpits was resolving at the time of this report. The clinical outcome of the event tingling nerve pain in the right arm was resolved on 14Apr2021, after a duration of 24 hours.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Pain in both armpits; Nausea; Headache; Swollen painful lump in arm; Tingling for 24 hours in right arm; Nerve pain for 24 hours in right arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 14:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included migraines, fibromyalgia, anxiety and depression. The patient had known allergies to penicillin, sulfa drugs, mango and pears. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and duloxetine hydrochloride (CYMBALTA); both for unspecified indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Apr2021 at 00:00, the patient experienced nausea, headache within a few hours of vaccination, swollen painful lump in arm and tingling nerve pain for 24 hours in right arm. On 15Apr2021 after 2 days of vaccination, the patient experienced pain in both armpits which continued for at least 48 hours (at the time of reporting). The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, headache, swollen painful lump in arm, pain in both armpits was resolving at the time of this report. The clinical outcome of the event tingling nerve pain in the right arm was resolved on 14Apr2021, after a duration of 24 hours.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Lymphadenopathy, Nausea, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 29-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 29, via an unspecified route of administration, left arm, on Apr 14, 2021, at 11:00, single dose for COVID-19 immunisation. Medical history included COVID-19. The patient has allergies to sulfa. Prior to the vaccination, patient diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 15, 2021, at 06:00, patient experienced dizziness, sore arm, swollen lymph node underarm, nausea and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of dizziness, sore arm, swollen lymph node underarm, nausea and headache: not resolved (at the time of this report). No follow-up attempts  needed. Information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hypersensitivity, Pain, Periorbital swelling
Clinical narrative: Ache at injection site; Body aches; Chills; Massive headache; Aggravation of allergy; Hives; Itching; Puffy eyes; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 14:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 16Mar2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021 at 23:00, the patient experienced ache at injection site, body aches, chills, massive headache, aggravation of allergy causing hives/itching, puffy eyes and all started late night/ overnight after injection. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the reported events. The clinical outcome of the event ache at injection site, body aches, chills, massive headache, aggravation of allergy causing hives/itching, puffy eyes was resolved on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria, Vaccination site pain
Clinical narrative: Ache at injection site; Body aches; Chills; Massive headache; Aggravation of allergy; Hives; Itching; Puffy eyes; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 14:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 16Mar2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021 at 23:00, the patient experienced ache at injection site, body aches, chills, massive headache, aggravation of allergy causing hives/itching, puffy eyes and all started late night/ overnight after injection. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the reported events. The clinical outcome of the event ache at injection site, body aches, chills, massive headache, aggravation of allergy causing hives/itching, puffy eyes was resolved on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a noncontactable consumer (patient). A 29-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot#  EW0161), at the age of 29, via an unspecified route of administration, on Apr 14, 2021, at 16:00, single dose, for COVID-19 immunisation. Medical history included major depressive disorder and COVID-19. The patient has no known allergies to medications, food or other products. Concomitant medications taken within two weeks of vaccination included bupropion 300 milligram daily for unknown indication from unknown date. Prior to the vaccination, patient was diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 14, 2021, patient experienced fever, body aches, fatigue and a feeling like brain/thought was foggy. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of fever, body aches, fatigue and a feeling like brain/thought was foggy was resolving at the time of this report. No follow-up attempts possible. No further information expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Urticaria
Clinical narrative: Urticarial rash; Hand swelling; This is a spontaneous report from a contactable physician. A 17-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11Apr2021 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included depression. It was unknown if the patient was pregnant at the time of vaccination. Concomitant medications included sumatriptan (IMITREX) and escitalopram oxalate (LEXAPRO) for unknown indication from an unknown date. The patient previously received cefdinir (OMNICEF) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 10:00, the patient experienced urticarial rash and hand swelling. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with antihistamine (unspecified) on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events urticarial rash and hand swelling was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Neck pain, Pain in extremity
Clinical narrative: Arm sore for a couple of days; Headaches every day, all day.; Terrible pain in the back of the neck and head; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 12:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included Vitamin D, Multivitamin, and Bupropion all for unknown indications from an unknown date. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 14:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 08:00 the patient experienced arm sore for a couple of days, headaches every day, all day. Terrible pain in the back of the neck and head for the past several days and was not subsiding. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm sore, headaches, terrible pain in the back of the neck, and head was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Malaise, Myalgia, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0164), at the age of 62, via an unspecified route of administration, left arm, on Apr 13, 2021, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient previously took the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EP6955), via an unspecified route of administration, left arm, on Mar 23, 2021, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. On Apr 14, 2021, patient experienced occasional cough, muscle aches, low fever, headache and general malaise. The events did not result in doctor/other healthcare professional office/clinic visit,  emergency room/department or urgent care. Therapeutic measures not taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of the occasional cough, muscle ache, low fever, headache and general malaise recovered on an unknown date in Apr 2021. No follow-up attempts needed. No further information expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Myalgia
Clinical narrative: lethargic; muscle aches; This is a spontaneous report from a contactable consumer. A 53-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Mar2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and pollen allergy. Prior to vaccination, the patient was diagnosed with COVID-19 on an unknown date. Concomitant medications included atorvastatin calcium (LIPITOR), lisinopril (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN), all for unknown indications on unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021 at 10:30, the patient experienced muscle aches and was lethargic. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lethargic and muscle aches was resolved on an unknown date in Apr2021.The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Apr2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site pain; This is a spontaneous report from a contactable consumer. A 29-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 10:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included unspecified birth control medication from an unknown date for an unknown indication and unknown if ongoing. It was unknown if the patient was pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced injection site pain. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event injection site pain was resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 37-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6205), at the age of 37, via an unspecified route of administration, left arm, on Mar 30, 2021, at 17:30, single dose, for COVID-19 immunisation. Medical history not reported. The patient has no allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications included Contrave (naltrexone hydrochloride/bupropion hydrochloride), for an unknown indication; from an unknown date. Previously, patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6202), at the age of 37, via an unspecified route of administration, left arm, on Mar 9, 2021, at 16:30, single dose, for COVID-19 immunisation. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. On Apr 2, 2021, at 10:00, patient reported the Friday after receiving the second dose of the Pfizer COVID-19 vaccine, she broke-out in hives. The patient never had hives in her life. The only new thing she encountered recently was the vaccine. Therapeutic measures taken as a result of hives included treatment with Benadryl.  Since the vaccination, patient has not tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event hives: not recovered (at the time of this report). No follow-up attempts needed. No further information expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever from 100.5 up 101.7.  Fever had been for 4 days continuously.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302), via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient previously took clarithromycin (BIAXIN) and azithromycin (MANUFACTURER UNKNOWN); both on unknown dates for unspecified indications and experienced drug allergy. On 13Apr2021 at 13:30, the patient experienced fever from 100.5 up 101.7.  Fever had been for 4 days continuously. Therapeutic measures were not taken as a result of the event. On 13Apr2021 at 13:30, the patient underwent lab test and procedure which included body temperature and result was shown as from 100.5 up 101.7 (units unspecified). On 16Apr2021, the patient underwent SARS-CoV2-test (nasal swab) and the result was pending. The clinical outcome of the event fever from 100.5 up 101.7, fever had been for 4 days continuously was not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Ear pain, Hypoaesthesia, Mass, Oropharyngeal pain
Clinical narrative: 2nd injection got numbness; face got itchy; then got red raised bumps on legs; sore throat and ears, pain in chest.; sore throat and ears, pain in chest.; sore throat and ears, pain in chest.; This is a spontaneous report from a contactable consumer or other non health care professional. A 41-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 16Apr2021 15:00 (Batch/Lot Number: EW0170) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medication included tizanidine (TIZANIDINE) taken for an unspecified indication, start and stop date were not reported. The patient experienced 2nd injection got numbness, face got itchy, then got red raised bumps on legs, sore throat and ears, pain in chest (non-serious) on unspecified date. The outcome of the events were recovered with sequelae.  No follow-up attempts are needed as information about lot/batch number obtained.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: 2nd injection got numbness; face got itchy; then got red raised bumps on legs; sore throat and ears, pain in chest.; sore throat and ears, pain in chest.; sore throat and ears, pain in chest.; This is a spontaneous report from a contactable consumer or other non health care professional. A 41-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 16Apr2021 15:00 (Batch/Lot Number: EW0170) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medication included tizanidine (TIZANIDINE) taken for an unspecified indication, start and stop date were not reported. The patient experienced 2nd injection got numbness, face got itchy, then got red raised bumps on legs, sore throat and ears, pain in chest (non-serious) on unspecified date. The outcome of the events were recovered with sequelae.  No follow-up attempts are needed as information about lot/batch number obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Pyrexia
Clinical narrative: Low grade fever; fatigue; dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 15Apr2021 at 17:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) from an unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 03Mar2021 at 12:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 11:00, the patient experienced low grade fever, fatigue and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events low grade fever, fatigue and dizziness was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Left arm was so painful for almost 48 hours after the second dose; I could barely move the arm, making it difficult to dress/undress, put the arm on my chair's armrest, etc.; This is a spontaneous report from a non-contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm left on 15Apr2021 at 10:00 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 10:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an15Apr2021, the patient's left arm was so painful for almost 48 hours after the second dose and could barely move the arm, making it difficult to dress/undress, put the arm on the chair's armrest, etc. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm was so painful for almost 48 hours after the second dose and could barely move the arm, making it difficult to dress/undress, put the arm on the chair's armrest, etc. was recovered on 16Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased
Clinical narrative: dizziness; rapid heart beat; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 18:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Other medical history included food allergy and environmental allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced dizziness and rapid heartbeat lasted for 1 to 2 minutes. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of dizziness and rapid heartbeat was recovered on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Confusional state, Disturbance in attention, Dizziness
Clinical narrative: Tightness in chest; Weird heartbeat; Tingling/numbing sensation on face; Tingling/numbing sensation on face; Dizziness; Confused/trouble focusing; Confused/trouble focusing; Nausea; Pain at injection site; Chills; Headache; Itchy face; Tired; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 14:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and lower back pain. The patient had no other issues. The patient had latex allergy, no known allergies but suspected soft shell crab, shrimp allergy, allergy to something in some surgical masks and nitrile gloves ("must special order for work"), skin reaction and headaches to some fragrances, deodorants, lotions, etc. and potentially developing seasonal allergies recently. The patient had never tested for allergies. Concomitant medications included acetylsalicylic acid/ caffeine/ paracetamol (EXCEDRIN) for migraine on an unknown date and bismuth subsalicylate (PEPTO BISMOL) for an unknown indication from an unknown date; both were unknown if ongoing. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received flu vaccine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced dizziness and nausea twice which passed within 15 minutes. On 15Apr2021 at 14:45, immediately after the vaccination, the patient experienced tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site and later the patient experienced chills, headache, nausea, itchy face, pain at injection site and was tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site, chills, headache, itchy face and tired were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heart rate irregular, Hypoaesthesia, Nausea
Clinical narrative: Tightness in chest; Weird heartbeat; Tingling/numbing sensation on face; Tingling/numbing sensation on face; Dizziness; Confused/trouble focusing; Confused/trouble focusing; Nausea; Pain at injection site; Chills; Headache; Itchy face; Tired; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 14:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and lower back pain. The patient had no other issues. The patient had latex allergy, no known allergies but suspected soft shell crab, shrimp allergy, allergy to something in some surgical masks and nitrile gloves ("must special order for work"), skin reaction and headaches to some fragrances, deodorants, lotions, etc. and potentially developing seasonal allergies recently. The patient had never tested for allergies. Concomitant medications included acetylsalicylic acid/ caffeine/ paracetamol (EXCEDRIN) for migraine on an unknown date and bismuth subsalicylate (PEPTO BISMOL) for an unknown indication from an unknown date; both were unknown if ongoing. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received flu vaccine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced dizziness and nausea twice which passed within 15 minutes. On 15Apr2021 at 14:45, immediately after the vaccination, the patient experienced tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site and later the patient experienced chills, headache, nausea, itchy face, pain at injection site and was tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site, chills, headache, itchy face and tired were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus, Vaccination site pain
Clinical narrative: Tightness in chest; Weird heartbeat; Tingling/numbing sensation on face; Tingling/numbing sensation on face; Dizziness; Confused/trouble focusing; Confused/trouble focusing; Nausea; Pain at injection site; Chills; Headache; Itchy face; Tired; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 14:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and lower back pain. The patient had no other issues. The patient had latex allergy, no known allergies but suspected soft shell crab, shrimp allergy, allergy to something in some surgical masks and nitrile gloves ("must special order for work"), skin reaction and headaches to some fragrances, deodorants, lotions, etc. and potentially developing seasonal allergies recently. The patient had never tested for allergies. Concomitant medications included acetylsalicylic acid/ caffeine/ paracetamol (EXCEDRIN) for migraine on an unknown date and bismuth subsalicylate (PEPTO BISMOL) for an unknown indication from an unknown date; both were unknown if ongoing. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received flu vaccine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and experienced dizziness and nausea twice which passed within 15 minutes. On 15Apr2021 at 14:45, immediately after the vaccination, the patient experienced tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site and later the patient experienced chills, headache, nausea, itchy face, pain at injection site and was tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tightness in chest, weird heartbeat, tingling/numbing sensation on face, dizziness, confused/trouble focusing, nausea, pain at injection site, chills, headache, itchy face and tired were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Somnolence
Clinical narrative: Very sore arm.; Very very sleepy.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 08:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported.  Concomitant medications included estrogen (MANUFACTURER UNKNOWN) and phendimetrazine tartrate (BONTRIL), both taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 14:00, the patient experienced very sore arm and very very sleepy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events very sore arm and very very sleepy were resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.